Clinical Trials in New York

Showing 12581-12600 of 21,350 trials

Cannabinoid Medication for Adults With OCD

NCT02911324

The purpose of this pilot research study is to test the effects of a medication called nabilone (Cesamet) in adults with obsessive-compulsive disorder (OCD). Participants will receive either nabilone on its own, or nabilone in combination with a form of cognitive-behavioral therapy (CBT) called exposure and response prevention (EX/RP). Nabilone is a synthetic cannabinoid and acts on the brain's "endocannabinoid system," which has been hypothesized to play a role in OCD. Nabilone is approved by the FDA for the treatment of chemotherapy-induced nausea and vomiting. It is not FDA-approved for treating OCD.

Obsessive-Compulsive Disorder

New York State Psychiatric Institute16 participantsStarted Sep 2016

New York, New York, United States

COMPLETEDPhase 3< 1 mile

Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor

NCT01000662

All patients (with Stages 0-II breast cancer) will receive an accelerated three week regimen of prone whole breast radiotherapy. The study intends to test the hypothesis that a weekly boost to the tumor bed, delivered on Friday, before the weekend break, is as well tolerated as the daily boost during accelerated prone radiotherapy.

Breast Cancer

NYU Langone Health412 participantsStarted Mar 2009

New York, New York, United States • New York, New York, United States • New York, New York, United States

Cannabinoid Medication for Adults With OCD

Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor

Find Trials by Condition in New York

Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).

Non-Invasive Imaging of Atherosclerosis

FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)

Alpha Lipoic Acid in Geographic Atrophy

Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6

Investigating and Characterizing the Immune Response to Prostate Cancer

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

50 Human Subject Repeat Insult Patch Test

Multi-Center Study of New Medications to Treat Vaginal Infections

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Lorcaserin in the Treatment of Cocaine Use Disorder

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding

Study of the Native Outflow Tract Transcatheter Pulmonary Valve (TPV)